trending Market Intelligence /marketintelligence/en/news-insights/trending/8a_ujqm-wuohaj6v4hh7qg2 content esgSubNav
In This List

Calyxt appoints CEO

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Calyxt appoints CEO

Calyxt Inc. appointed James Blome CEO with effect from Oct. 1.

The Minnesota-based gene-editing agriculture company is a unit of Paris-based biotech company Cellectis S.A.

Calyxt's former CEO Yves Ribeill remains a board member.

Blome was the CEO and president of Bayer Crop Science and has more than 25 years of experience in the agriculture industry. He also held executive positions at Agriliance LLC prior to Bayer.